Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received a suspension order for a Drug License from the Assistant Director, Drugs Control Administration, Warangal, Telangana. The suspension is for two days affecting a store located at Station Road Jangaon, Telangana. The order was received on April 2, 2026, citing violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945. The company estimates a potential revenue loss of Rs 0.16 lac due to this suspension. This disclosure is made pursuant to SEBI regulations requiring prompt intimation of material events.
The impact is minimal as only one store is affected for two days with a small estimated revenue loss of Rs 0.16 lac. This is unlikely to materially affect the company's stock price or operations given the limited scope.